Evidence map›Paper›PMID 28587391›Full record

ArticleExperimental and therapeutic medicine2017

Immunoregulatory effects of the traditional Dai prescription Yajieshaba on food allergic mice.

Guangyuan Zhang, Xiaohua Duan, Chao Zhang, Pu Chen, Jie Yu, Jin Zheng

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Yajieshaba prevents lipopolysaccharide-induced intestinal barrier injuryanti-inflammatory and anti-apoptosis.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Guangyuan ZhangCollege of Chinese Materia Medica, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China.
Xiaohua DuanCollege of Ethnopharmacy, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China.
Chao ZhangCollege of Ethnopharmacy, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China.
Pu ChenCollege of Ethnopharmacy, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China.
Jie YuCollege of Chinese Materia Medica, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China.
Jin ZhengCollege of Ethnopharmacy, Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, P.R. China.
Yunnan University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Dai prescription Yajieshaba is widely used in Traditional Dai Medicine to treat food allergies and intolerance. However, information on the active chemical ingredients, effects and mechanisms of action of Yajieshaba is limited. The present study aimed to elucidate the effects and underlying mechanisms of Yajieshaba in the treatment of food allergies. Liquid chromatography with a diode array detector was used to measure the levels of palmatine and berberine, the active ingredients of Yajieshaba. A food allergy model was established in female BALB/c mice by three injections of ovalbumin (OVA) at 0, 48, and 96 h. OVA-sensitized mice recieved no treatments (control), Yajieshaba, loratadine, palmatine or berberine. The scratching frequency, serum immunoglobulin (Ig)G, IgE, interleukin (IL)-4, IL-10, IL-17, IL-21, interferon-γ and tumor necrosis factor-α levels were assessed at 50 and 98 h. The percentage of regulatory T cells (Tregs) was evaluated by flow cytometry at 98 h. The scratching frequency induced by OVA was significantly suppressed in mice treated with loratadine, palmatine, berberine or 3.50 and 4.70 g/kg Yajieshaba. The frequency of CD4

Indexed as

CD4+CD25+Foxp3+ regulatory T cellsovalbuminYajieshaba

Identifiers

PMID28587391
PMCPMC5450608
OpenAlexW2612975624

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.